» Articles » PMID: 35465787

Neural Plasticity of the Uterus: New Targets for Endometrial Cancer?

Abstract

Endometrial carcinoma is the most common gynecological malignancy in Western countries and is expected to increase in the following years because of the high index of obesity in the population. Recently, neural signaling has been recognized as part of the tumor microenvironment, playing an active role in tumor progression and invasion of different solid tumor types. The uterus stands out for the physiological plasticity of its peripheral nerves due to cyclic remodeling brought on by estrogen and progesterone hormones throughout the reproductive cycle. Therefore, a precise understanding of nerve-cancer crosstalk and the contribution of the organ-intrinsic neuroplasticity, mediated by estrogen and progesterone, of the uterine is urgently needed. The development of new and innovative medicines for patients with endometrial cancer would increase their quality of life and health. This review compiles information on the architecture and function of autonomous uterine neural innervations and the influence of hormone-dependent nerves in normal uterus and tumor progression. It also explores new therapeutic possibilities for endometrial cancer using these endocrine and neural advantages.

Citing Articles

Estrogen Promotes Endometrial Cancer Development by Modulating ZNF626, SLK, and RFWD3 Gene Expression and Inducing Immune Inflammatory Changes.

Fan J, Zhang M, Wu H, Ye Z, Wang L Biomedicines. 2025; 13(2).

PMID: 40002911 PMC: 11853163. DOI: 10.3390/biomedicines13020498.


Advanced Insights into Human Uterine Innervation: Implications for Endometriosis and Pelvic Pain.

Astruc A, Roux L, Robin F, Sall N, Dion L, Lavoue V J Clin Med. 2024; 13(5).

PMID: 38592287 PMC: 10932059. DOI: 10.3390/jcm13051433.


Reclassification of endometrial cancer and identification of key genes based on neural-related genes.

Chen F, Qin T, Zhang Y, Wei L, Dang Y, Liu P Front Oncol. 2022; 12:951437.

PMID: 36212450 PMC: 9537575. DOI: 10.3389/fonc.2022.951437.

References
1.
Guo J, Zhang Y, Qian H, Ma F, Cui X, Duan H . The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?. Arch Gynecol Obstet. 2019; 300(5):1399-1404. DOI: 10.1007/s00404-019-05318-2. View

2.
Zoubina E, Smith P . Sympathetic hyperinnervation of the uterus in the estrogen receptor alpha knock-out mouse. Neuroscience. 2001; 103(1):237-44. DOI: 10.1016/s0306-4522(00)00549-2. View

3.
Grytli H, Fagerland M, Fossa S, Tasken K . Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. 2013; 65(3):635-41. DOI: 10.1016/j.eururo.2013.01.007. View

4.
Arnold J, Barcena de Arellano M, Ruster C, Vercellino G, Chiantera V, Schneider A . Imbalance between sympathetic and sensory innervation in peritoneal endometriosis. Brain Behav Immun. 2011; 26(1):132-41. DOI: 10.1016/j.bbi.2011.08.004. View

5.
Lakoski S, Jones L, Krone R, Stein P, Scott J . Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms. Am Heart J. 2015; 170(2):231-41. PMC: 4548856. DOI: 10.1016/j.ahj.2015.05.014. View